Recent Articles
World-first study uses DNA to investigat...
A world-first Australian study is using DNA to identify a person’s genetic risk of developing multiple sclerosis (MS) to understand how their immune system responds to a common virus linked to the disease.
Promising antiviral drugs identified for...
Australian researchers have identified four existing antiviral medications that show promise in treating Multiple Sclerosis (MS), potentially opening a new frontier in MS treatment.
First NMOSD-specific treatment recommend...
Exciting progress has been made for the NMOSD community with the Pharmaceutical Benefits Advisory Committee (PBAC) recommending ravulizumab (Ultomiris®) for PBS listing.
MS Australia launches national research ...
MS Australia has taken a major step forward in multiple sclerosis research with the launch of a new national collaborative platform focused on understanding the relationship between Epstein-Barr virus (EBV) and MS.
New report calls for faster MS diagnosis...
A new report has revealed the prolonged time to diagnose multiple sclerosis (MS) and highlighted the urgent need for increased investment in MS research and enhanced awareness of the disease.
